156 related articles for article (PubMed ID: 20082478)
1. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
[TBL] [Abstract][Full Text] [Related]
2. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Hiraki M; Kitajima Y; Koga Y; Tanaka T; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2011 Oct; 18(10):3013-9. PubMed ID: 21409489
[TBL] [Abstract][Full Text] [Related]
3. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
[TBL] [Abstract][Full Text] [Related]
4. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
[TBL] [Abstract][Full Text] [Related]
8. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
Hu SL; Huang DB; Sun YB; Wu L; Xu WP; Yin S; Chen J; Jiang XD; Shen G
Med Oncol; 2011 Jun; 28(2):447-54. PubMed ID: 20300977
[TBL] [Abstract][Full Text] [Related]
9. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.
Gao YJ; Xin Y; Zhang JJ; Zhou J
World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
12. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study.
Fujiwara Y; Okada K; Hanada H; Tamura S; Kimura Y; Fujita J; Imamura H; Kishi K; Yano M; Miki H; Okada K; Takayama O; Aoki T; Mori M; Doki Y
Surgery; 2014 Mar; 155(3):417-23. PubMed ID: 24439740
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.
Leong KJ; Beggs A; James J; Morton DG; Matthews GM; Bach SP
Br J Surg; 2014 Sep; 101(10):1299-309. PubMed ID: 25052224
[TBL] [Abstract][Full Text] [Related]
14. The Detection of Messenger RNA for Carcinoembryonic Antigen and Cytokeratin 20 in Peritoneal Washing Fluid in Patients with Advanced Gastric Cancer.
Kim YJ; Chung WC; Choi S; Jung YD; Lee J; Chae SY; Jun KH; Chin HM
Korean J Gastroenterol; 2017 Apr; 69(4):220-225. PubMed ID: 28449423
[TBL] [Abstract][Full Text] [Related]
15. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
16. CpG island methylation of BNIP3 predicts resistance against S-1/CPT-11 combined therapy in colorectal cancer patients.
Hiraki M; Kitajima Y; Nakafusa Y; Nakamura J; Hashiguchi K; Sumi K; Noshiro H; Miyazaki K
Oncol Rep; 2010 Jan; 23(1):191-7. PubMed ID: 19956881
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.
Mitsuno M; Kitajima Y; Ide T; Ohtaka K; Tanaka M; Satoh S; Miyazaki K
J Gastroenterol; 2007 Nov; 42(11):866-73. PubMed ID: 18008030
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
Oki E; Zhao Y; Yoshida R; Masuda T; Ando K; Sugiyama M; Tokunaga E; Morita M; Kakeji Y; Maehara Y
World J Gastroenterol; 2009 May; 15(20):2520-5. PubMed ID: 19469003
[TBL] [Abstract][Full Text] [Related]
19. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
